Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests

Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests

Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of analytical toxicology 2023-09
Hauptverfasser: Hart, E Dale, Mullen, Lawrance, Vikingsson, Svante, Cone, J Edward, Winecker, E Ruth, Hayes, D Eugene, Flegel, Ronald R
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Journal of analytical toxicology
container_volume
creator Hart, E Dale
Mullen, Lawrance
Vikingsson, Svante
Cone, J Edward
Winecker, E Ruth
Hayes, D Eugene
Flegel, Ronald R
description Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nano-emulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of Δ9-THC even in the absence of added surfactants. Three THC-free CBD products; an oil, an anhydrous powder, and a water-soluble formulation were incubated for 3 hours in SGF without SDS. The water-soluble CBD product produced a dispersion while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (
doi_str_mv 10.1093/jat/bkad043
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37440360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37440360</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-b649fc7822beb8b116ccfe206383677893d16adb878fd69430ccaf4548a3c8fa3</originalsourceid><addsrcrecordid>eNo1j81OAjEYABsTI4ievJvvBSrttnS7R11FTEi84Jn0FwvL7mbbYngPn8tnEqOeJpnDJIPQDSV3lFRsulVpqnfKEs7O0JhWfIYLTtgIXca4JYQKKdgFGrGSn6wgY9TXXXtwQwxdC52HD5XcgGPXZN04qB8eIXXw9Vnh1aKG0EI8tundpWBgo2IaTvRNDhYwqBZy24Sda45gVI7uJ9d3MaRwcGCHvIHkYopX6NyrJrrrP07Q2_xpVS_w8vX5pb5f4p4SmbAWvPKmlEWhnZaaUmGMdwURTDJRlrJilgpltSylt6LijBijPJ9xqZiRXrEJuv3t9lnvnV33Q9ir4bj-X2ff-zxa0w</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hart, E Dale ; Mullen, Lawrance ; Vikingsson, Svante ; Cone, J Edward ; Winecker, E Ruth ; Hayes, D Eugene ; Flegel, Ronald R</creator><creatorcontrib>Hart, E Dale ; Mullen, Lawrance ; Vikingsson, Svante ; Cone, J Edward ; Winecker, E Ruth ; Hayes, D Eugene ; Flegel, Ronald R</creatorcontrib><description>Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nano-emulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of Δ9-THC even in the absence of added surfactants. Three THC-free CBD products; an oil, an anhydrous powder, and a water-soluble formulation were incubated for 3 hours in SGF without SDS. The water-soluble CBD product produced a dispersion while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (&lt;0.0006% conversion), and up to 0.063% and 0.0045% conversion to Δ9-THC was observed with the water-soluble CBD and the CBD powder, respectively. No formation of Δ8-THC was observed. In comparison, when the nano-formulated CBD was incubated in SGF with 1% SDS, 33-36% conversion to Δ9-THC was observed. Even though the rate of conversion with the water-soluble CBD was at least 100-fold higher compared to the CBD oil, it was still smaller than Δ9-THC levels reported in CBD products labelled "THC-free" or "&lt;0.3% THC" based on the Agricultural Improvement Act of 2018 (the Farm Bill). Assuming a daily CBD dose of around 30 mg/day, it is unlikely that conversion of CBD to Δ9-THC could produce a positive urinary drug test for Δ9-THC-COOH (15 ng/mL cutoff).</description><identifier>EISSN: 1945-2403</identifier><identifier>DOI: 10.1093/jat/bkad043</identifier><identifier>PMID: 37440360</identifier><language>eng</language><publisher>England</publisher><ispartof>Journal of analytical toxicology, 2023-09</ispartof><rights>Published by Oxford University Press 2023. This work is written by (a) US Government employee(s) and is in the public domain in the US.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-5977-3049 ; 0000-0001-9397-8582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37440360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hart, E Dale</creatorcontrib><creatorcontrib>Mullen, Lawrance</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Cone, J Edward</creatorcontrib><creatorcontrib>Winecker, E Ruth</creatorcontrib><creatorcontrib>Hayes, D Eugene</creatorcontrib><creatorcontrib>Flegel, Ronald R</creatorcontrib><title>Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests</title><title>Journal of analytical toxicology</title><addtitle>J Anal Toxicol</addtitle><description>Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nano-emulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of Δ9-THC even in the absence of added surfactants. Three THC-free CBD products; an oil, an anhydrous powder, and a water-soluble formulation were incubated for 3 hours in SGF without SDS. The water-soluble CBD product produced a dispersion while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (&lt;0.0006% conversion), and up to 0.063% and 0.0045% conversion to Δ9-THC was observed with the water-soluble CBD and the CBD powder, respectively. No formation of Δ8-THC was observed. In comparison, when the nano-formulated CBD was incubated in SGF with 1% SDS, 33-36% conversion to Δ9-THC was observed. Even though the rate of conversion with the water-soluble CBD was at least 100-fold higher compared to the CBD oil, it was still smaller than Δ9-THC levels reported in CBD products labelled "THC-free" or "&lt;0.3% THC" based on the Agricultural Improvement Act of 2018 (the Farm Bill). Assuming a daily CBD dose of around 30 mg/day, it is unlikely that conversion of CBD to Δ9-THC could produce a positive urinary drug test for Δ9-THC-COOH (15 ng/mL cutoff).</description><issn>1945-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo1j81OAjEYABsTI4ievJvvBSrttnS7R11FTEi84Jn0FwvL7mbbYngPn8tnEqOeJpnDJIPQDSV3lFRsulVpqnfKEs7O0JhWfIYLTtgIXca4JYQKKdgFGrGSn6wgY9TXXXtwQwxdC52HD5XcgGPXZN04qB8eIXXw9Vnh1aKG0EI8tundpWBgo2IaTvRNDhYwqBZy24Sda45gVI7uJ9d3MaRwcGCHvIHkYopX6NyrJrrrP07Q2_xpVS_w8vX5pb5f4p4SmbAWvPKmlEWhnZaaUmGMdwURTDJRlrJilgpltSylt6LijBijPJ9xqZiRXrEJuv3t9lnvnV33Q9ir4bj-X2ff-zxa0w</recordid><startdate>20230915</startdate><enddate>20230915</enddate><creator>Hart, E Dale</creator><creator>Mullen, Lawrance</creator><creator>Vikingsson, Svante</creator><creator>Cone, J Edward</creator><creator>Winecker, E Ruth</creator><creator>Hayes, D Eugene</creator><creator>Flegel, Ronald R</creator><scope>NPM</scope><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0001-9397-8582</orcidid></search><sort><creationdate>20230915</creationdate><title>Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests</title><author>Hart, E Dale ; Mullen, Lawrance ; Vikingsson, Svante ; Cone, J Edward ; Winecker, E Ruth ; Hayes, D Eugene ; Flegel, Ronald R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-b649fc7822beb8b116ccfe206383677893d16adb878fd69430ccaf4548a3c8fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hart, E Dale</creatorcontrib><creatorcontrib>Mullen, Lawrance</creatorcontrib><creatorcontrib>Vikingsson, Svante</creatorcontrib><creatorcontrib>Cone, J Edward</creatorcontrib><creatorcontrib>Winecker, E Ruth</creatorcontrib><creatorcontrib>Hayes, D Eugene</creatorcontrib><creatorcontrib>Flegel, Ronald R</creatorcontrib><collection>PubMed</collection><jtitle>Journal of analytical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hart, E Dale</au><au>Mullen, Lawrance</au><au>Vikingsson, Svante</au><au>Cone, J Edward</au><au>Winecker, E Ruth</au><au>Hayes, D Eugene</au><au>Flegel, Ronald R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests</atitle><jtitle>Journal of analytical toxicology</jtitle><addtitle>J Anal Toxicol</addtitle><date>2023-09-15</date><risdate>2023</risdate><eissn>1945-2403</eissn><abstract>Cannabidiol (CBD) has been shown to convert to Δ9-tetrahydrocannabinol (Δ9-THC) in acidic environments, raising a concern of conversion when exposed to gastric fluid after consumption. Using synthetic gastric fluid (SGF), it has been demonstrated that the conversion requires surfactants, such as sodium dodecyl sulfate (SDS), due to limited solubility of CBD. Recently, water-compatible nano-emulsions of CBD have been prepared as a means of fortifying beverages and water-based foods with CBD. Since these emulsions contain surfactants as part of their formulation, it is possible that these preparations might enhance the production of Δ9-THC even in the absence of added surfactants. Three THC-free CBD products; an oil, an anhydrous powder, and a water-soluble formulation were incubated for 3 hours in SGF without SDS. The water-soluble CBD product produced a dispersion while the powder and the oil did not mix with the SGF. No THC was detected with the CBD oil (&lt;0.0006% conversion), and up to 0.063% and 0.0045% conversion to Δ9-THC was observed with the water-soluble CBD and the CBD powder, respectively. No formation of Δ8-THC was observed. In comparison, when the nano-formulated CBD was incubated in SGF with 1% SDS, 33-36% conversion to Δ9-THC was observed. Even though the rate of conversion with the water-soluble CBD was at least 100-fold higher compared to the CBD oil, it was still smaller than Δ9-THC levels reported in CBD products labelled "THC-free" or "&lt;0.3% THC" based on the Agricultural Improvement Act of 2018 (the Farm Bill). Assuming a daily CBD dose of around 30 mg/day, it is unlikely that conversion of CBD to Δ9-THC could produce a positive urinary drug test for Δ9-THC-COOH (15 ng/mL cutoff).</abstract><cop>England</cop><pmid>37440360</pmid><doi>10.1093/jat/bkad043</doi><orcidid>https://orcid.org/0000-0001-5977-3049</orcidid><orcidid>https://orcid.org/0000-0001-9397-8582</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1945-2403
ispartof Journal of analytical toxicology, 2023-09
issn 1945-2403
language eng
recordid cdi_pubmed_primary_37440360
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Conversion of water-soluble CBD to Δ9-THC in synthetic gastric fluid - an unlikely cause of positive drug tests
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T12%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conversion%20of%20water-soluble%20CBD%20to%20%CE%949-THC%20in%20synthetic%20gastric%20fluid%20-%20an%20unlikely%20cause%20of%20positive%20drug%20tests&rft.jtitle=Journal%20of%20analytical%20toxicology&rft.au=Hart,%20E%20Dale&rft.date=2023-09-15&rft.eissn=1945-2403&rft_id=info:doi/10.1093/jat/bkad043&rft_dat=%3Cpubmed%3E37440360%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37440360&rfr_iscdi=true